Safety of Thrombolysis in Acute Ischemic Stroke: A Review of Complications, Risk Factors, and Newer Technologies

Intravenous recombinant tissue plasminogen activator (r-tPA) was approved for use in acute ischemic stroke in the United States in 1996. Approximately 2% to 5% of patients with acute ischemic stroke receive r-tPA. Complications related to intravenous r-tPA include symptomatic intracranial hemorrhage...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Miller, Daniel J., Simpson, Jennifer R., Silver, Brian
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2011
Teme:
Improving Health Care Quality: Reviews
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3726129/
https://ncbi.nlm.nih.gov/pubmed/23983849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1941875211408731
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki